Bolton LP’s Abeona Therapeutics ABEO Stock Holding History

Bolton LP’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-260	Closed	-$33K	–	128
2015 Q2	$33K	Buy	+260	New	+$39.1K	0.01%	176

Other funds holding ABEO

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Bolton LP's ABEO Position: Q3 2015 in Review

Bolton LP sold out of Abeona Therapeutics (ABEO) in Q3 2015, closing a stake of 260 shares — an estimated $33K sold.

Bolton LP first reported a position in ABEO in Q2 2015 and held it in 1 quarter. The position peaked at $33K in Q2 2015. 43 funds tracked by Wall St. Rank hold ABEO as of Q3 2015.

Bolton LP reported no remaining Abeona Therapeutics position as of Q3 2015 after selling out during the quarter.
Bolton LP sold 260 Abeona Therapeutics shares in Q3 2015, an estimated $33K.
Bolton LP first reported a position in Abeona Therapeutics in Q2 2015 and held it in 1 quarter.
Bolton LP's Abeona Therapeutics position peaked at $33K in Q2 2015.
43 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2015.

Based on Bolton LP's 13F filing for Q3 2015, filed 16 Nov 2015.